Skip to main content
    E

    Exicure Inc (XCUR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.07
    -0.01 (-0.93%)

    Market Cap: $7.07M

    Last updated: Nov 17, 2026 at 10:55 AM ET

    Exicure Inc (XCUR) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Exicure are Ensysce Biosciences (ENSC), In8bio (INAB) and Soligenix (SNGX). By market cap, Exicure ranks 7th of the 13 companies on this page; Intensity Therapeutics, Inc. Common stock (INTS) is the largest at $10.17M.

    Peer Comparison

    XCUR's revenue growth of 928.0% is above the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Exicure (XCUR)$7.07MN/AN/A0.0%N/A928.0%0.00%
    Ensysce Biosciences Inc (ENSC)$8.14MN/A1.2x-280.5%-260.6%-15.1%0.00%
    In8bio Inc (INAB)$8.86MN/AN/A0.0%N/A0.0%0.00%
    Soligenix Inc. (SNGX)$7.50MN/AN/A0.0%N/A-100.0%0.00%
    Enveric Biosciences Inc (ENVB)$6.78MN/A0.2x0.0%N/A-7.3%0.00%
    Theriva Biologics Inc. (TOVX)$6.61MN/A21.5x0.0%-52.3%0.0%0.00%
    CNS Pharmaceuticals Inc (CNSP)$4.22MN/AN/A0.0%N/A0.0%0.00%
    Skye Bioscience, Inc. Common Stock (SKYE)$4.83MN/AN/A0.0%-3685.3%0.0%0.00%
    GT Biopharma Inc (GTBP)$7.67MN/AN/A0.0%N/A0.0%0.00%
    Imunon Inc (IMNN)$4.08MN/AN/A0.0%-131.5%0.0%0.00%
    Intensity Therapeutics, Inc. Common stock (INTS)$10.17MN/AN/A0.0%N/A0.0%0.00%
    Moleculin Biotech Inc (MBRX)$8.02MN/AN/A0.0%N/A0.0%0.00%
    Senti Biosciences Inc (SNTI)$5.38MN/A57.2x0.0%1039.8%-100.0%0.00%
    Peer median$7.14MN/A11.4x0.0%-131.5%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Exicure, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Ensysce Biosciences Inc (ENSC)
    Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs.
    ENSC competitors
    In8bio Inc (INAB)
    IN8bio, Inc., a clinical-stage biotechnology company, is focused on developing new therapies for the treatment of cancers...
    INAB competitors
    Soligenix Inc. (SNGX)
    Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States.
    SNGX competitors
    Enveric Biosciences Inc (ENVB)
    Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer.
    ENVB competitors
    Theriva Biologics Inc. (TOVX)
    Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need.
    TOVX competitors
    CNS Pharmaceuticals Inc (CNSP)
    CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central...
    CNSP competitors
    Skye Bioscience, Inc. Common Stock (SKYE)
    Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops...
    SKYE competitors
    GT Biopharma Inc (GTBP)
    GT Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its...
    GTBP competitors
    Imunon Inc (IMNN)
    Imunon Inc. is a clinical-stage biotechnology company at the forefront of developing innovative immune-mediated therapies targeting cancer and infectious...
    IMNN competitors
    Intensity Therapeutics, Inc. Common stock (INTS)
    Intensity Therapeutics, Inc. is a pioneering biotechnology firm committed to revolutionizing cancer treatment through cutting-edge drug delivery systems.
    INTS competitors
    Moleculin Biotech Inc (MBRX)
    Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of cancer drug candidates for the treatment of highly resistant...
    MBRX competitors
    Senti Biosciences Inc (SNTI)
    Senti Biosciences Inc (SNTI) is a leading biotechnology firm specializing in synthetic biology...
    SNTI competitors

    Frequently Asked Questions About XCUR

    Who are Exicure's main competitors?

    The companies most similar to Exicure include Ensysce Biosciences (ENSC), In8bio (INAB), Soligenix (SNGX), Enveric Biosciences (ENVB) and Theriva Biologics (TOVX), listed from the closest match.

    Who is Exicure's biggest competitor?

    Intensity Therapeutics, Inc. Common stock (INTS) is the largest of the similar companies at $10.17M; Ensysce Biosciences (ENSC) is the closest match by business profile, size, sector and industry.

    How does XCUR stock compare with its competitors?

    XCUR's net margin is 0.0% against a peer median of 0.0%.

    Which of Exicure's competitors pays a higher dividend?

    Exicure pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Exicure bigger than its competitors?

    No. Exicure is 7th by market cap among the 13 companies on this page; the largest is Intensity Therapeutics, Inc. Common stock (INTS) at $10.17M.